运动处方长期干预对体力活动不足患者的随机对照试验
该随机对照试验纳入190例27-77岁体力活动不足且伴代谢危险因素的患者,在既往6个月常规运动处方治疗无应答后,随机接受理疗师强化支持或继续常规运动处方治疗2年。结果显示两组体力活动水平、代谢健康和健康相关生活质量均有改善,但组间无显著差异,表明运动处方在初级保健中可行。
要点
- 运动处方长期干预可改善体力活动不足患者的体力活动水平、代谢健康和健康相关生活质量。
- 理疗师强化支持与常规运动处方治疗相比,2年时各结局指标无显著组间差异。
- 运动处方在常规初级保健中可行,患者和医疗系统均可从代谢危险因素改善中获益。
核心结论
- 在长期运动处方干预期间,代谢风险患者的体力活动水平、代谢健康和健康相关生活质量均有所提高,组间无显著差异。
- 结果表明这些改善独立于药物治疗的任何变化。
- 运动处方在常规初级保健中可行,患者和医疗系统均从代谢危险因素改善中获益。
研究设计与样本
- 随机对照试验,纳入190例27-77岁体力活动不足且伴代谢危险因素的患者。
- 患者在既往6个月常规运动处方治疗无应答后,随机分为理疗师强化支持组或继续常规运动处方治疗组,干预2年。
- 运动处方包括个体化对话、个体化剂量体力活动建议(含书面处方)和结构化随访;理疗师组额外接受有氧适能测试和更频繁的预定随访。
主要发现
- 2年随访时,理疗师组62.9%和常规组50.8%的患者体力活动水平增加。
- 2年随访时,理疗师组31.4%和常规组38.5%的患者达到每周≥150分钟中等强度体力活动,组间差异无统计学意义。
- 2年间两组高密度脂蛋白升高(p=0.004 vs 基线)、心理健康状态(MCS)改善(p=0.036)、体重指数降低(p=0.001),组间无差异。
临床怎么用
- 在初级保健中可实施运动处方治疗,包括个体化对话、书面处方和结构化随访。
- 对于常规运动处方治疗无应答的体力活动不足患者,继续运动处方干预仍可能改善体力活动、代谢健康和健康相关生活质量。
- 理疗师强化支持与常规运动处方治疗相比未显示额外获益,可根据资源选择干预强度。
局限性
- 未来研究需阐明有效的长期运动处方治疗策略。
- 试验注册为回顾性注册。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Physical activity (PA) can be used to prevent and treat diseases. In Sweden, licensed healthcare professionals use PA on prescription (PAP) to support patients to increase their PA level. The aim of this randomized controlled trial was to evaluate a 2-year intervention of two different strategies of PAP treatment for patients with insufficient PA level, after a previous 6-month period of ordinary PAP treatment in a primary health care setting. METHODS: We included 190 patients, 27-77 years, physically inactive with metabolic risk factors where the patients were not responding to a previous 6-month PAP treatment with increased PA. The patients were randomized to either enhanced support from a physiotherapist (PT group) or continued ordinary PAP treatment at the health care centre (HCC group). The PAP treatment included an individualized dialogue; an individually dosed PA recommendation, including a written prescription; and a structured follow-up. In addition to PAP, the PT group received aerobic fitness tests and more frequent scheduled follow-ups. The patient PA level, metabolic health, and health-related quality of life (HRQOL) were measured at baseline and at 1- and 2-year follow-ups. RESULTS: At the 2-year follow-up, 62.9% of the PT group and 50.8% of the HCC group had increased their PA level and 31.4% vs. 38.5% achieved ≥ 150 min of moderate-intensity PA/week (difference between groups n.s.). Over 2 years, both groups displayed increased high-density lipoproteins (HDL) (p = 0.004 vs. baseline), increased mental health status (MCS) (p = 0.036), and reduced body mass index (BMI) (p = 0.001), with no difference between groups. CONCLUSION: During long-term PAP interventions, the PA level, metabolic health, and HRQOL increased in patients at metabolic risk without significant differences between groups. The results indicate to be independent of any changes in pharmacological treatment. We demonstrated that the PAP treatment was feasible in ordinary primary care. Both the patients and the healthcare system benefitted from the improvement in metabolic risk factors. Future studies should elucidate effective long-term PAP-treatment strategies. TRIAL REGISTRATION: ClinicalTrials.gov NCT03012516 . Registered on 30 December 2016-retrospectively registered.
引用
- Lundqvist S, Börjesson M, Cider Å, et al. Long-term physical activity on prescription intervention for patients with insufficient physical activity level-a randomized controlled trial. Trials. 2020. PMID: 32933577. doi:10.1186/s13063-020-04727-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。